Log In
BCIQ
Print this Print this
 

BPH-652

  Manage Alerts
Collapse Summary General Information
Company AuricX Pharmaceuticals Inc.
DescriptionAnti-infective agent
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationStaphylococcus
Indication DetailsTreat Staphylococcus aureus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today